Blue Horseshoe Stocks: AVGO Options Recap & More

Broadcom, Inc. AVGO – Recap

To close out the week on Friday, we took our usual approach in signaling some last-minute options ideas for possible daytrades. In this particular case, we were attracted to the AVGO Weekly $252.50-257.50 Calls, and we’re pleased to report total success on that front, with the help of an eleven-dollar swing from AVGO shares themselves.

All three of the contract sets contained within our designated range produced impressive gain opportunities on the day. The total possible profits for daytraders on each set were as follows: 

$252.50 Calls – Range: 7.95-13.65 – Max Gain: 72%
$255 Calls – Range: 6.14-11.00 – Max Gain: 95%
$257.50 Calls – Range: 2.70-8.00 – Max Gain: 196%
_____

FRESH OPTIONS IDEA: 

We’ll also formulate a new options idea to start off the week this morning. The market looks like it wants to turn around again today, so we’ll go ahead and slate the SPY 06/19 $289-290.50 Calls as our ones to watch.  



BOTTOM WATCHLIST:

We’ve also got a three pack of bottom plays with freshly reported earnings today. We’ll place all of the following on watch for possible rebounds this week.

Freds, Inc. FRED
FuelCell Energy, Inc. FCEL
Fang Holdings, Ltd. SFUN


Extended Watchlist:
ALTD, DLYT, XRF, BPMC, SHIP, ROX, CJ, NVUS, PES

Blue Horseshoe Stocks: EXCLUSIVE AMPG INTERVIEW

AmpliTech Group, Inc. AMPG

We’ve been keeping track of AMPG for ten weeks now, and not only did the stock make a run from .043 to .084 during that time, but it has managed to hold more than half of those gains upon consolidation, and has held firm in the .065-.075 area.

For a company that, for the time being, is rather small in size, AmpliTech has serviced some big accounts in both the government and private sectors. The company’s RF signal amplifiers are top of the line in terms of noise reduction effectiveness, and AMPG exhibited its wares at a recent high profile conference.

We were pleased to attend the 2019 International Microwave Symposium in Boston, Massachusetts last week, where we got the opportunity to sit down and conduct a face-to-face interview with Fawad Maqbool, the CEO of AmpliTech. We highly recommend that you take a few moments to check it out.


VIEW AMPG INTERVIEW NOW!


RH, Inc. RH – Recap

Our bearish options trading idea from yesterday’s report turned out to be our bigger winner for the day. We selected the  RH Weekly $120-118 Puts even after the company posted a solid beat on Q1 earnings and raised guidance.

It might have seemed like a counter-intuitive choice to some, but we had good reason. The stock was gapping up way too high in the premarket. We predicted that it would fall after the open, and it turned out to be the right hunch.

The following intraday gains were made possible by our idea:

RH Weekly $120-118 Puts
$120 Puts: 3.80-8.40 (+121%)
$119 Puts: 3.90-6.75 (+73%)
$118 Puts: 3.00-6.29 (+110%)

____

Fresh Options Idea:
AVGO Weekly $252.50-257.50 Calls

Important: DO NOT attempt to trade options contracts with a weekly expiration on a Friday unless you are an advanced level trader with access to disposable funds.


Extended Watchlist:
NVCN, NAKD, HUSA, ARQL, KURA, IGC, LGCY, FVPR

Blue Horseshoe Stocks: Solid Runners

SOLID RUNNERS

We tagged both INSY and HSGX in yesterday morning’s premarket report, and both stocks produced admirable runs on the day. 

INSYS Therapeutics, Inc. INSY just registered its lowest price ever earlier this week, and we thought it would be worth it to track as a potential bottom-bounce play. The return was instantaneous. INSY opened at a low of .32 before running as high as .74, which marks an intraday pop of 131%

There is still a huge gap to the topside on the chart, so we’ll definitely continue to monitor the activity on INSY in the days and weeks ahead.
_____

Histogenics Corp. HSGX was also a solid mover for us on the day yesterday. This stock has traded mostly flat for the whole of 2019 so far, but it looks like we tagged it as a bottom play at an opportune moment.

From a low of .24 it reached .32 for a respectable 33% gain, but this could just be the beginning. We’ll want to continue tracking this play as well.

_____

FRESH OPTIONS IDEAS: 
Lululemon Athletica LULU Weekly $177.50-182.50 Calls
Duluth Holdings, Inc. DLTH  08/16 $15-17.50 Calls
RH, Inc. RH Weekly $120-118 Puts 


Extended Watchlist:
SMRT, LTBR, NAKD, AMR, ADT, RRGB, YUMA

Blue Horseshoe Stocks: Options Updates

MGM Resorts International Inc. MGM

On Monday morning, we issued a Form-4 alert on MGM after witnessing more than $75M in insider buying at a bottom pour in over the course of the previous three sessions.

We can usually have a fairly high rate of confidence that a stock in this situation will produce a rebound, and so far that’s just what we’ve seen. We signaled the MGM 08/16 $28-30 Calls for tracking, and so far, we’ve seen some pretty nice moves.

$28 Calls – Range: 1.09-1.80 – Max Gain: 65%
$29 Calls – Range: .96-1.32 – Max Gain: 38%
$30 Calls – Range: .68-.95 – Max Gain: 40%

There is plenty of time to continue to look after this idea, which could certainly produce further gains from this point forward.
_____

Turtle Beach Corp. HEAR

We also added a pair of options contracts to watch in the HEAR chain last Thursday, and while we also have plenty of time to realize added gains in this case as well, the early performance out of these has been noteworthy, especially the $15′s which have already recorded a multi-bag move.

HEAR 10/18 $12.50-15 Calls.
$12.50 Calls – Range: .60-.90 – Max Gain: 50%
$15 Calls – Range: .20-.50 – Max Gain: 150%
_____

FRESH OPTIONS IDEA: 
Dave & Busters Entertainment Inc. PLAY  07/26 $40-45 Calls 


Ocular Therapeutix, Inc. OCUL – Recap

We also wanted to quickly mention the performance of OCUL since we alerted on the stock last month. It has produced quite a dip and rip since that time, touching a low of 2.38 before running as high as 4.08. That marks a total possible gain of 71% in a span of just over three weeks.



Extended Watchlist:
NETS, TBLT, JILL, HSGX, FBIO, RIOT, INSY(Bottom-bouncer)

Blue Horseshoe Stocks: CHMJF Review

chemistree-technology-logo-1
Chemistree Technology, Inc.
(OTCMKTS:CHMJF) (CSE:CHM)

We are circling back to revisit CHMJF this morning, a stock that we recently profiled operating in the cannabis space. Our regular followers are certainly aware of our predisposition toward the industry, as a thriving, relatively new market space that is setting up to flourish well into the future.

The company is actively pursuing the development of vertically integrated cannabis assets in multiple states, including the design and build-out of tens of thousands of square feet of greenhouse and processing facility space. The company has interests in both the retail and medical sectors, and in both flower and by-product form (e.g. CBD/Hemp Extract).

We previously commented on the incredible past year the company’s had in terms of executing its strategy of acquiring and developing assets in various areas of the cannabis business. That’s one of the primary draws for us in this case. at the end of last month, CHMJF management laid out what we can expect from the company in the next year.

First off, CHMJF plans to continue to seek out new opportunities in the Western United States, in addition to its Sugarleaf cannabis brand in Washington and prospective grow/processing operation in marijuana ‘hot zone’, Desert Hot Springs, California. It will also optimize the Sugarleaf operation through expansion of its existing facilities, slated for completion in August of this year. In terms of the California project, we’re looking at a slightly longer timetable, with the first greenhouse tentatively scheduled to go up in the 1st quarter of 2020.

We’re very interested to continue tracking the multiple irons the company has in the fire, but for the time being, we are also very interested in the technical setup of the chart.

The early spring brought solid moves for CHMJF stock, as it traded up from a low of .3145 in March, to as much as .597 in April. After a period of consolidation, the stock recently saw a low of .313, and has begun to show signs of another leg-up. After seeing that 90% move previously, we are very interested to see if CHMJF can mount another run of a similar or perhaps even more significant nature.

We encourage readers to launch their own due diligence into CHMJF, and also check out the following video presentation of the current CHMJF chart. 

CHMJF VIDEO CHART:

_____

FRESH CHMJF NEWS: 

VANCOUVER, June 10, 2019 /PRNewswire/ – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that its partner Applied Cannabis Sciences of New Jersey (“ACS”), is readying an Application under the new Request for Applications (RFA) program announced by the Department of Health on June 3, 2019. In total, the Department will seek up to 24 cultivation endorsements, up to 30 manufacturing endorsements, and up to 54 dispensary endorsements. As allowable, ACS will be applying for all three permit types, creating a vertically integrated model for the business. (>>Read Full PR)
_____

For More Information on CHMJF, visit:
chemistree.ca/